Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.
Matthew N MillsAkihiro UnoPinxue LiCasey LiveringhouseYoungchul KimDaniel E OliverBradford A PerezBenjamin C CreelanMichael YuPeter A ForsythYolanda PinaKamran A AhmedPublished in: Clinical lung cancer (2024)
The prognosis for patients with NSCLC LMD remains poor overall. However, the receipt of ETT for patients with EGFR-positive disease was associated with improved outcomes.